Harriet De Wit to Genetic Predisposition to Disease
This is a "connection" page, showing publications Harriet De Wit has written about Genetic Predisposition to Disease.
Connection Strength
0.414
-
Association between impulsivity traits and body mass index at the observational and genetic epidemiology level. Sci Rep. 2019 11 26; 9(1):17583.
Score: 0.091
-
Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders. Nat Neurosci. 2018 12; 21(12):1656-1669.
Score: 0.085
-
Genetic influences on ADHD symptom dimensions: Examination of a priori candidates, gene-based tests, genome-wide variation, and SNP heritability. Am J Med Genet B Neuropsychiatr Genet. 2017 Jun; 174(4):458-466.
Score: 0.077
-
More on ADORA. Psychopharmacology (Berl). 2010 Dec; 212(4):699-700.
Score: 0.048
-
Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology. 2008 Nov; 33(12):2791-800.
Score: 0.040
-
GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia. Nat Neurosci. 2018 09; 21(9):1161-1170.
Score: 0.021
-
Genome-wide association study of alcohol use disorder identification test (AUDIT) scores in 20 328 research participants of European ancestry. Addict Biol. 2019 01; 24(1):121-131.
Score: 0.020
-
Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder. JAMA Psychiatry. 2015 Jul; 72(7):642-50.
Score: 0.017
-
Genetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder. Proc Natl Acad Sci U S A. 2014 Apr 22; 111(16):5968-73.
Score: 0.015